Wetter Pharma-Fertigung GmbH & Co. KG (manufacturing of unpackaged products, primary packaging)

Ukraine

All drugs from this manufacturer

  • BONVIVA

    The drug is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures.

    Dosage form: solution for injection

    Active substance Dosage
    ibandronic acid 3 mg

    ATC: M05BA06